This Organisation is not specific to Greece. For more details, please visit OpenAIRE Explore.
Powered by OpenAIRE Graph Last update of records in OpenAIRE: Oct 18, 2026
Found an issue? Give us feedback
corporate_fareOrganisationNon-Profit

Teva Pharmaceuticals (Israel)

Organisation website
Location
location_onIsrael
Identifiers
ROR: https://ror.org/01wfv3m53
ISNI: 000000012189710X

Projects(12)

  • assignment_turned_inProjectOpen Access Mandate for Publications and Datasets

    Breakthrough Regulatory Innovation and Development throuGh sandbox Environments (BRIDGE)
    Ongoing

    Nov 2025 - Oct 2028
    European CommissionHEOverall Budget: €9,355,430.00 Funder contribution: €5,199,810.00 Grant: HORIZON-JU-IHI-2024-08-two-stage-101219311
    Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation
  • assignment_turned_inProjectOpen Access Mandate for Publications

    Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials (Trials@Home)
    Completed

    Sep 2019 - Nov 2025
    European CommissionH2020Overall Budget: €37,454,000.00 Funder contribution: €19,037,000.00 Grant: H2020-JTI-IMI2-2018-14-two-stage-831458
    Centre Of Excellence – Remote Decentralised Clinical TrialsCentre Of Excellence – Remote Decentralised Clinical TrialsCentre Of Excellence – Remote Decentralised Clinical Trials
  • assignment_turned_inProjectOpen Access Mandate for Publications and Datasets

    European Quality In Preclinical Data (EQIPD)
    Completed

    Oct 2017 - Sep 2021
    European CommissionH2020Overall Budget: €9,360,690.00 Funder contribution: €4,495,520.00 Grant: H2020-JTI-IMI2-2016-09-two-stage-777364
    DATA QUALITY IN PRECLINICAL RESEARCH AND DEVELOPMENTDATA QUALITY IN PRECLINICAL RESEARCH AND DEVELOPMENTDATA QUALITY IN PRECLINICAL RESEARCH AND DEVELOPMENT
  • assignment_turned_inProjectOpen Access Mandate for Publications

    Bio-orthogonal catalysis for cancer therapy (THERACAT)
    Completed

    Mar 2018 - Aug 2022
    European CommissionH2020Overall Budget: €3,380,770.00 Funder contribution: €3,380,770.00 Grant: H2020-MSCA-ITN-2017-765497
    Innovative Training NetworksInnovative Training NetworksInnovative Training Networks
  • assignment_turned_inProjectOpen Access Mandate for Publications and Datasets

    Real World Handling of Protein Drugs - Exploration, Evaluation and Education (RealHOPE)
    Completed

    Jul 2021 - Jun 2025
    European CommissionH2020Overall Budget: €7,132,610.00 Funder contribution: €3,139,980.00 Grant: H2020-JTI-IMI2-2020-20-two-stage-101007939
    Handling of protein drug products and stability concernsHandling of protein drug products and stability concernsHandling of protein drug products and stability concerns
  • chevron_left
  • 1
  • 2
  • 3
  • chevron_right

Data sources

Recent Publications

Recent Research data

Recent Research software

Recent Other research products

Parent Organisations

N/A

Child Organisations

N/A

Versions (4)

  • corporate_fareOrganisation

    TEVA PHARMACEUTICAL INDUSTRIES LIMITED

  • corporate_fareOrganisation

    TEVA PHARMACEUTICAL INDUSTRIES LIMITED

  • corporate_fareOrganisation

    TEVA(Teva Pharmaceutical Industries, Ltd)

  • corporate_fareOrganisation

    Teva Pharmaceuticals (Israel)